Galapagos NV
GLPG
#4857
Rank
A$2.72 B
Marketcap
A$40.53
Share price
1.12%
Change (1 day)
5.83%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : A$4.02 Billion

According to Galapagos NV's latest financial reports the company has A$4.02 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$4.84 B6.85%
2023-12-31$A$4.53 B13.92%
2022-12-31$A$3.98 B-3.57%
2021-12-31$A$4.12 B-3.33%
2020-12-31$A$4.27 B-7.16%
2019-12-31$A$4.60 B133.34%
2018-12-31$A$1.97 B26.78%
2017-12-31$A$1.55 B40.48%
2016-12-31$A$1.10 B102.09%
2015-12-31$A$0.54 B78.83%
2014-12-31$A$0.30 B18.38%
2013-12-31$A$0.25 B71.63%
2012-12-31$A$0.15 B0.56%
2011-12-31$A$0.14 B-22.9%
2010-12-31$A$0.19 B11.99%
2009-12-31$A$0.17 B3.92%
2008-12-31$A$0.16 B1.44%
2007-12-31$A$0.16 B-10.17%
2006-12-31$A$0.18 B85.25%
2005-12-31$A$98.97 M444.65%
2004-12-31$A$18.17 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$114.42 B 2,739.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$74.05 B 1,737.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-A$4.53 Billion-212.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$118.20 B 2,833.43%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$73.89 B 1,733.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$68.36 B 1,596.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$30.15 B 648.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A$91.47 M-97.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$11.10 B 175.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel